University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 16 of 27
Patient Centered-Rehabilitation ver111090.1
NCT03034954
Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy
NCT02936843
Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents
NCT02909946
Post-Physical Therapy Extension of In-Home Dynamic Standing Table Use in Parkinson Disease
NCT03045211
Blood Flow Restriction to Improve Muscle Strength After ACL Injury
NCT03141801
Interrupting Prolonged Sitting With Activity
NCT03256188
The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
NCT02622386
Helping Employees Lose Pounds
NCT02853877
Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement
NCT02920177
The Effects of Gastric or Duodenal Nutrient Infusion on Food Intake, Obesity and Comorbidities in Obese Individuals
NCT02880813
Impact of Physical Activity for Chronic Pelvic Pain
NCT02867774
Sleep Therapy for Insomnia and Depression
NCT02943278
Prehabilitation for PAD Revascularization Patients
NCT02767895
Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
NCT02837549
Immunologic Profile of Chronically Photodamaged Skin
NCT02889159
Lifestyle Intervention for Adults With Diabetes
NCT02699307
A Pilot Study of a Brief Pre-Operative Intervention for Patients Undergoing Breast Surgery
NCT02939040
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576
Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults
NCT02706093
Myofascial Pain and Central Sensitization
NCT04929171
Modulating Interaction of Motor Learning Networks in Rehabilitation of Stroke
NCT03086551
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
NCT02760654
Project Nexus: Providing Online Counseling for Home-Based HIV Testing
NCT02335138
Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients
NCT02966002
Study of Cognition and Control in Youths
NCT03393390
Taking Charge of Systemic Sclerosis
NCT02494401
Cryoanesthesia for Intravitreal Injections
NCT02872012
Fostering Sustainability Through Diabetes Self-Management Support
NCT03021746
True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners
NCT02702453
Protection Against Insulin Resistance in Obesity
NCT02717832
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
NCT02786524
Visual and Auditory Neuromodulation of Pain Perception
NCT04281836
Web-Delivered Interventions for Blood Sugar Control for Individuals With Type 2 Diabetes
NCT02676648
Prehabilitation for Aortic Repair Patients
NCT02767518
Longitudinal Study of Innate Lymphoid Cells in Peripheral Blood in ALS
NCT03090932
Impact of Exercise on the Metabolic Consequences of Overeating
NCT02701738
Improving Motor Skill Development in Infants After Cardiac Surgery
NCT02700646
Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study)
NCT02701751
Effectiveness of Silver Diamine Fluoride as a Treatment for Caries in Comparison to Traditional Restorative Techniques
NCT02601833
Sleep-Disordered Breathing and PAP in Perinatal Depression
NCT02507297
1/2 A Multi-site Systems Intervention for Unemployed Persons With Social Anxiety
NCT02633267
Characterization of Adults for Asthma Microbiome Research Studies
NCT02887911
An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients
NCT02669563
Esthetic Outcomes of Immediately Placed Implants Receiving Immediate Provisionalization and Delayed Restoration
NCT01925339
CPAP to Treat Cognitive Dysfunction in MS
NCT02544373
Nocturnal Mouth Guards, SOVA vs. Standard Acrylic Orthotic; Phase IV
NCT02340663
Study of the Safety of QRH-882260 Heptapeptide
NCT02574858
Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus
NCT02629497
Celtra Duo Computer Assisted Design/Computer Assisted Machining (CAD/CAM) Dental Crown Study
NCT03036579
Diagnostic Accuracy of Doppler Resistive Indices for Early Diagnosis of Acute Kidney Injury .
NCT02580292
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.